This webcast explores clinical cases illustrating the use of a dACM construct for the management of wounds.

This webcast discusses new and emerging therapies, with regard to their mechanisms of action, indications, efficacy, and cost-effectiveness.

Recorded during the AHSP Midyear Meeting, this webcast discusses translating outcomes from T2DM cardiovascular trials into clinical practice to implement individualized management strategies for patients with T2DM at high risk of or with a history of CVD.

This webcast explores research, science and clinical evidence surrounding the evolution of regenerative medical approaches to burn healing.

This webcast on advanced breast cancer reviews the patient and disease characteristics that inform individualized treatment selection and sequencing.

This webcast examines the most recent evidence-based guidelines to optimize individualized tyrosine kinase inhibitor (TKI) selection for CML patients based on disease phase, treatment history, genetic mutation profile, and comorbidities.

This webcast summarizes the role of genetic mutations and patient-specific biomarkers in therapeutic selection and pathway design for NSCLC.

This webcast discusses recent therapeutic advances, resource utilization data, and current guidance into AML clinical pathways discussions.

This webcast discusses the impact of integrating new and innovative therapies into clinical guidelines and pathways.

This webcast discusses current guideline recommendations for ovarian cancer and strategies to improve the incorporation of recommendations into clinical pathways for ovarian cancer treatment.